Bayer Overview

  • Founded
  • 1863
Founded
  • Status
  • Public
  • Employees
  • 99,637
Employees
  • Stock Symbol
  • BAYN
Stock Symbol
  • Investments
  • 66
  • Share Price
  • $55.10
  • (As of Monday Closing)

Bayer General Information

Description

Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins. The company has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.

Contact Information

Website
www.bayer.com
Formerly Known As
Farbenfabriken Bayer, Farbenfabriken Bayer AG
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Agricultural Chemicals
Stock Exchange
ETR
Primary Office
  • Kaiser-Wilhelm-Allee 1
  • 51373 Leverkusen
  • Germany
+49 0214 000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bayer Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$55.10 $56.63 $49.63 - $69.72 $55.6B 982M 3.58M $1.21

Bayer Financials Summary

In Thousands,
USD 		TTM 31-Dec-2021 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 91,387,581 91,387,581 91,131,991 122,154,053
Revenue 52,116,906 52,116,906 47,192,395 48,746,222
EBITDA 7,947,411 7,947,411 (13,300,504) 9,900,369
Net Income 1,182,299 1,182,299 (11,963,386) 4,579,648
Total Assets 136,139,354 136,139,354 143,665,055 141,336,589
Total Debt 44,757,818 44,757,818 51,113,735 43,554,530
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bayer Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bayer‘s full profile, request access.

Request a free trial

Bayer Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and
Pharmaceuticals
Leverkusen, Germany
99,637 As of 2021
00.00
0000 0000-00-00
000000000 00.00

00000 (0

, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut
000000000000000
Sao Paulo, Brazil

0000000

d tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercita
0000 000000000
Ness Ziona, Israel
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bayer Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bayer (Brazil) Corporation Sao Paulo, Brazil
0000000 Formerly VC-backed Ness Ziona, Israel 000 00000 000000000 00000
00000000 000000000 Corporation Gaithersburg, MD 0000 00000 000000000 00000
000000 00000 Corporation Mumbai, India 0000
00000 Corporation Darmstadt, Germany 00000 00.00 00000000 00.00
You’re viewing 5 of 5 competitors. Get the full list »

Bayer Patents

  • 148,752

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1,307

    Granted

  • 4,213

    Pending

  • 000

    Expiring in next 12 mo

Bayer Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-102021001957-A1 Tablet dispenser with dosing aid Withdrawn 30-Apr-2020 0000000000 0
EP-3900530-A1 Liquid management for a catching device Pending 23-Apr-2020 00000000 00
EP-3900530-A4 Liquid management for a catching device Pending 23-Apr-2020 00000000
EP-3900722-A1 Combination of finerenone and pecavaptan for the treatment and/or prevention of cardiovascular and/or renal diseases Withdrawn 22-Apr-2020 00000000000 0
EP-3900722-A4 Combination of finerenone and pecavaptan for the treatment and/or prevention of cardiovascular and/or renal diseases Withdrawn 22-Apr-2020 A61K31/4375
To view Bayer’s complete patent history, request access »

Bayer Executive Team (46)

Name Title Board Seat Contact Info
Sebastian Guth President, Bayer Pharmaceuticals Americas & Member of the Global Executive Committee
Johannes Dietsch Chief Financial Officer and Member of the Board of Management
Wolfgang Nickl Chief Financial Officer and Member of the Board of Management
Jeffrey Jarrett NA Chief Marketing Officer, Bayer Consumer Health
Gerrit Plum Director, Mergers & Acquisitions
You’re viewing 5 of 46 executive team members. Get the full list »

Bayer Board Members (37)

Name Representing Role Since
0000000 0000000 Self Board Member 000 0000
00000 000 000000 Bayer Board Member 000 0000
000000 000000 Bayer Board Member 000 0000
0000000 0000000 Self Board Member 000 0000
000000 00000000 Bayer Board Member 000 0000
You’re viewing 5 of 37 board members. Get the full list »

Bayer Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bayer Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bayer‘s full profile, request access.

Request a free trial

Bayer Investments & Acquisitions (66)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 08-Mar-2022 0000000000 Personal Products
00000000 0000 01-Aug-2021 0000000000 00.00 Drug Discovery 000000 00
00000 0000000 03-Jun-2021 0000000000 Drug Discovery 000000 00
000 000000 30-May-2021 0000 00000 00000 Other Services (B2C Non-Financial)
Care/of 01-Feb-2021 Merger/Acquisition 00000 Other Pharmaceuticals and Biotechnology 000 00000
You’re viewing 5 of 66 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

Bayer Subsidiaries (16)

Company Name Industry Location Founded
BlueRock Therapeutics Drug Discovery Cambridge, MA 2016
0000000 Other Pharmaceuticals and Biotechnology New York, NY 0000
00000 00 00000 Corporate Venture Capital Leverkusen, Germany 0000
00000000 000000000 Drug Discovery San Diego, CA 0000
000000000 Personal Products Hamburg, Germany 0000
You’re viewing 5 of 16 subsidiaries. Get the full list »

Bayer Exits (18)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 00000000 26-Nov-2019 00000 00000 00 000.00 Completed
  • 3 buyers
0000000 02-Jul-2018 0000 00000 00.00 Completed
  • 11 buyers
000000'0 00000000 02-Oct-2014 000000000000000000 Completed
  • 00000
00000000 01-Jan-2008 00000 0000000 Completed
  • 2 buyers
InPhase Technologies 01-Jan-2008 Later Stage VC 0000 Completed
  • 4 buyers
You’re viewing 5 of 18 exits. Get the full list »